Learn from the authors of AGA’s latest clinical practice guideline. Barrett’s esophagus (BE) is the pre-cursor to esophageal adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in eradicating BE and related neoplasia, but has greater risk of harms and resource use than surveillance endoscopy. This webinar provides clinicians with evidence-based practice recommendations for the use of EET in BE and related neoplasia. View the guideline here.

Learning objectives:

Guideline authors share best practices and provide:

• A comprehensive outline of the indications for EET in the management of BE and related neoplasia
• Guidance regarding the considerations surrounding implementation of EET
  

Speakers:

Sachin Wani, MD, AGAF
Katy O and Paul M Rady Endowed Chair in Esophageal Cancer Research
Professor of Medicine
Executive Director, Katy O and Paul M Rady Esophageal and Gastric Center of Excellence
Co-Director, GI Outcomes Research Group
Division of Gastroenterology and Hepatology
University of Colorado Anschutz Medical Campus

Tarek Sawas, MD, MPH
Assistant Professor of Medicine Advanced Endoscopy Fellowship Program Director Division of Digestive and Liver Diseases
University of Texas Southwestern, Dallas, TX

Joel H. Rubenstein, MD, MS, AGAF
Research Scientist, Veterans Affairs Center for Clinical Management Research
LTC Charles S. Kettles Veterans Affairs Medical Center Director,
Barrett’s Esophagus Program and Professor,
Division of Gastroenterology, University of Michigan Medical School

 

Swathi Eluri, MD MSCR
Senior Associate Consultant
Director, Esophageal Diseases Group
Division of Gastroenterology and Hepatology
Mayo Clinic Florida

Pricing:

Member	Nonmember
Free	Free

 

Original release date: June 11, 2024

Expiration date: June 26, 2026